Clonucopya: An end-to-end workflow bridging tumor clonal architecture and drug prioritization
Motivation Intra-tumor heterogeneity limits the effectiveness of anticancer treatments, as distinct clonal populations may respond differently to therapy. Although subclonal inference from sequencing data is well established, translating clonal architecture into actionable drug recommendations remains a major bottlenec...